Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00062101 Information provided by National Cancer Institute (NCI)

First Received: June 5, 2003 Last Updated: July 23, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)